Institut Jules Bordet

Academic/Hospital

Also known as: Institute Jules Bordet - Boulevard De Waterloo 125 - B-1000 Brussels, Belgium | Institut Jules Bordet/Clinical Trials Support Unit (IJB/CTSU)

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Jul 19, 2018

Last known activity

Aug 2, 2018

Timeline

No events for the selected filters.

Drugs by trial phase (7 distinct, 2 trials)

Phase 3 (4 own, 0 via acquisition)

atezolizumab
doxorubicin
paclitaxel
cyclophosphamide

Phase 1 (3 own, 0 via acquisition)

fulvestrant
trastuzumab
men1611

Indications

Studied for

Breast Neoplasms
Triple Negative Breast Neoplasms

Recent trials (2)

NCT03498716CollaboratorPhase 3Aug 2, 2018
NCT03767335Study chairPhase 1Jul 19, 2018

Details

Last known activity: Aug 2, 2018